Star Lake Technology: New Amino Acid Products Plan Sunine 2013 Resumed Production

2012, the company's operating income was RMB1,091 million, up 2.64% YoY; net profit attributable to shareholders of listed companies was RMB203 million, down 331.34% YoY; and net profit attributable to shareholders of listed companies, net profit after deducting non-recurring gains and losses, was RMB298 millionGJMIn the case of fierce market competition, the main product sales price decline, through the company's product restructuring and technical breakthrough, the development and input into the production of fructose, lysine, proline, adenine and other new products to increase sales revenue, while further expanding sales channels to develop new customers to increase product sales to expand sales scale, as well as increase the sales revenue of subsidiary products trade and export sales, so that the company in a difficult market environment to maintain a certain amount of total sales revenue growth, to achieve a basic balance of production and salesGJMThe company said the main reasons for the loss: objectively, the macroeconomic growth rate slows down, industry overcapacity and disorderly competition are the main factors, especially the taste nucleotide di sodium should face domestic overcapacity, disorderly competition, but also to face the dumping of Japanese and Korean enterprises;GJMDuring the reporting period, the company realized revenue of RMB 1,083 million, of which sales revenue of biochemical drugs was RMB330 million, an increase of 7.58 percent YoY, gross margin of 25.75 percent, down 2.96 percentage points YoY, mainly due to the increase in sales revenue of products, sub-yellow, adenosine, and new product adenine; 8.42 percentage points, mainly due to the increase in SALES of IMP and birdgine and sales revenue of new products fructose, feed additive sales revenue of 182 million yuan, a decrease of 47.61 percent YoY, gross margin -6.6 percent, a decrease of 5.68 percentage points YoY, although feed additives new development products lysine and proline make a certain increase in revenue, but due to the main product Suineline temporarily discontinued sales revenue according to market changesGJMIn addition, the company said that the temporary idle fixed assets are mainly for the production line temporarily idle, the production line company is expected to be remodeled in 2013 to resume production, after testing the production line does not have impairmentGJM2012, the Company's operating income was RMB1,091 million, up 2.64% YoY; net profit attributable to shareholders of listed companies was RMB203 million, down 331.34% YoY; and net profit attributable to shareholders of listed companies, net profit after non-recurring profit and loss, was RMB298 millionGJMIn the case of fierce market competition, the main product sales price decline, through the company's product restructuring and technical breakthrough, the development and input into the production of fructose, lysine, proline, adenine and other new products to increase sales revenue, while further expanding sales channels to develop new customers to increase product sales to expand sales scale, as well as increase the sales revenue of subsidiary products trade and export sales, so that the company in a difficult market environment to maintain a certain amount of total sales revenue growth, to achieve a basic balance of production and salesGJMThe company said the main reasons for the loss: objectively, the macroeconomic growth rate slows down, industry overcapacity and disorderly competition are the main factors, especially the taste nucleotide di sodium should face domestic overcapacity, disorderly competition, but also to face the dumping of Japanese and Korean enterprises;GJMDuring the reporting period, the company realized revenue of RMB 1,083 million, of which sales revenue of biochemical drugs was RMB330 million, an increase of 7.58 percent YoY, gross margin of 25.75 percent, down 2.96 percentage points YoY, mainly due to the increase in sales revenue of products, sub-yellow, adenosine, and new product adenine; 8.42 percentage points, mainly due to the increase in SALES of IMP and birdgine and sales revenue of new products fructose, feed additive sales revenue of 182 million yuan, a decrease of 47.61 percent YoY, gross margin -6.6 percent, a decrease of 5.68 percentage points YoY, although feed additives new development products lysine and proline make a certain increase in revenue, but due to the main product Suineline temporarily discontinued sales revenue according to market changesGJMIn addition, the company said that the temporary idle fixed assets are mainly for the production line temporarily idle, the production line company is expected to be remodeled in 2013 to resume production, after testing the production line does not have impairmentGJM